Bolhano, Vilma A.

HRN: 12-42-47  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/14/2026
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
08/14/2026
08/21/2026
IV
500mg
Q8h
Gastric Mass, Occult GI Bleeding
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Intra-abdominal    Compliance to guidelines: Compliant To Guidelines